Takeda Pharmaceutical
TAK
#418
Rank
S$74.83 B
Marketcap
S$23.69
Share price
0.65%
Change (1 day)
31.34%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): S$4.19 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are S$29.86 Billion. , an increase over its 2024 earnings that were of S$2.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 S$4.22 B49.03%
2024 S$2.83 B-2.41%
2023 S$2.90 B-28.14%
2022 S$4.03 B-40.9%
2021 S$6.83 B78.24%
2020 S$3.83 B246.1%
2019 S$1.10 B-48.79%
2018 S$2.16 B-23.64%
2017 S$2.83 B21.7%
2016 S$2.32 B-253.01%
2015 -S$1.53 Billion-159.65%
2014 S$2.55 B13%
2013 S$2.25 B2.46%
2012 S$2.20 B-57.05%
2011 S$5.12 B-10.49%
2010 S$5.72 B-3.99%
2009 S$5.96 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.12 B 874.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.75 B 391.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$15.04 B 256.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.46 B 147.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.55 B 173.64%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$29.30 B 594.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$11.83 B 180.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-S$1.01 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
S$1.10 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India